Опыт применения кеторолака в терапии острой боли


Котова О.В.

Отдел патологии вегетативной нервной системы НИЦ ГОУ ВПО “Первый Московский государственный университет им. И.М. Сеченова” Минздравсоцразвития России, Москва
В ситуации острого заболевания человека, которое сопровождается болью, важнейшей задачей фармакотерапии является максимально быстрое и полное обезболивание. Наиболее популярным классом лекарств, применяемых в качестве анальгетиков, особенно когда боль определяется наличием повреждения или воспаления тканей, являются нестероидные противовоспалительные средства (НПВС). Кеторолак – это НПВС, доступное в парентеральной и таблетированной формах, обладающее мощным обезболивающим потенциалом; его эффективность и безопасность хорошо изучены при лечении умеренной и сильной боли во многих клинических ситуациях и подтверждены в ряде исследований.

Литература


1. Eberson CP, Pacicca DM, Ehrlich MG. The role of ketorolac in decreasing length of stay and narcotic
complications in the postoperative pediatric orthopaedic patient. J Pediatr Orthop 1999; 9(5):688–92.
2. Larkin GL, Peacock WF, et al. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med 1999;17(1):6–10.


3. Perez-Urizar J, Granados-Soto V, et al. Analgesic efficacy and bioavailability of ketorolac in postoperative
pain: a probability analysis. Arch Med Res 2000;31(2):191–96.
4. Brown CR, Moodie JE, Dickie G, et al. Analgesic efficacy and safety of single-dose oral and intramuscular
ketorolac tromethamine for postoperative pain. Pharmacotherapy 1990; 10(6):59–70.
5. Dula DJ, Anderson R, Wood GC. A prospective study comparing i.m. ketorolac with i.m. meperidine
in the treatment of acute biliary colic. J Emerg Med 2001;20(2):121–24.
6. Henderson SO, Swadron S, Newton E. Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic. J Emerg Med 2002;23(3):237–41.
7. Barber FA, Gladu DE. Comparison of oral ketorolac and hydrocodone for pain relief after anterior
cruciate ligament reconstruction. Arthroscopy 1998;14(6):605–12.
8. Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties
and therapeutic use in pain management. Drugs 1997;53(1):139–88.
9. McGuire DA, Sanders K, Hendricks SD. Comparison of ketorolac and opioid analgesics in postoperative ACL reconstruction outpatient pain control. Arthroscopy 1993;9(6):653–61.
10. Kostamovaara PA, Hendolin H, Kokki H, Nuutinen LS. Ketorolac, diclofenac and ketoprofen are equally
efficacious for pain relief after total hip replacement surgery. Br J Anaesth 1998;81(3):369–72.
11. Chui PT, Gin T. A comparison between ketorolac and diclofenac in laparoscopic sterilization. Eur J
Anaesthesiol 1995;12(6):597–601.
12. Forrest JB, Camu F, Greer IA, et al. Ketorolac, diclofenac, and ketoprofen are equally safe for
pain relief after major surgery. Br J Anaesthesiol 2002;88(2):227–33.
13. Macario A, Lipman AG. Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal antiinflammatory
drugs: a systematic review of efficacy, side effects, and regulatory issues. Pain Med 2001;2(4):336–51.
14. De Oliveira GS Jr, Agarwal D, Benzon HT. Perioperative Single Dose Ketorolac to Prevent
Postoperative Pain: A Meta-Analysis of Randomized Trials. Anesth Analg 2011;29. [Epub ahead of print].
15. Veenema KR, Leahey N, Schneider S. Ketorolac versus meperidine: ED treatment of severe musculoskeletal low back pain. Am J Emerg Med 2000;18(4):404–07.
16. Innes GD, Croskerry P, et al. Ketorolac versus acetaminophen-codeine in the emergency department
treatment of acute low back pain. J Emerg Med 1998;16(4):549–56.
17. Rainer TH, Jacobs P, et al. Cost effectiveness analysis of intravenous ketorolac and morphine for treating
pain after limb injury: double blind randomised controlled trial. BMJ 2000;321(7271):1247–51.
18. Perlmutter A, Miller L, et al. Toradol, an NSAID used for renal colic, decreases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruction. J Urol 1993; 149(4):926–30.
19. Martan Carrasco C, Rodriguez Vazquez M, Palacios Garcia R. A double-blind study of the analgesic
efficacy in kidney colic of the combination of dipyrone and spasmolytic with ketorolac trometamol.
Arch Esp Urol 1993;46(9):763–68.
20. Cohen E, Hafner R, et al. Comparison of ketorolac and diclofenac in the treatment of renal colic. Eur J
Clin Pharmacol 1998;54(6):455–58.
21. Stein A, Ben Dov D, et al. Single-dose intramuscular ketorolac versus diclofenac for pain management
in renal colic. Am J Emerg Med 1996; 14(4):385–87.
22. Nicolas Torralba JA et al. Intramuscular ketorolac compared to subcutaneous tramadol in the initial
emergency treatment of renal colic. Arch Esp Urol 1999;52(5):435–37.
23. Wood VM, Christenson JM, et al. The NARC (Nonsteroidal Anti-inflammatory in Renal Colic) Trial. Single-dose intravenous ketorolac versus titrated intravenous meperidine in acute renal colic: a randomized clinical trial. CJEM 2000; 2(2):83–9.
24. Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on bone, tendon and ligament healing. Inflamm Res 2005;54:358–66.
25. Lamano Carvalho TL. Effect of conventional and COX-2 selective non-steroidal antiinflammatory
drugs on bone healing. Acta Ortop Bras 2007;15:166–68.
26. Poveda Roda R, Bagan JV, Jimenez Soriano Y, Gallud Romero L. Use of nonsteroidal antiinflammatory
drugs in dental practice. A review Med Oral Patol Oral Cir Bucal 2007;12(1):10–8.
27. Yugoshi LI, Sala MA, et al. Histometric study of socket healing after tooth extraction in rats treated
with diclofenac. Braz Dent J 2002;13:92–6.
28. Battisti N. The evaluation of the analgesic and antiinflammatory effects of flurbiprofen mouthwash
and 100-mg tablets in oral medicine. Minerva Stomatol 1994;43:141–44.
29. Gerstenfeld LC, Al-Ghawas M, et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint
Surg 2007;89:114–25.
30. Mullis BH, Copland ST, et al. Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on
a mouse fracture model. Injury 2006;37:827–37.
31. Fracon RN, Teofilo JM, MorisIC, Lamano T. Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats. J Appl Oral Sci 2010; 18(6):36–9.
32. Haragsim L, Dalal R, Bagga H, Bastani B. Ketorolac-induced acute renal failure and hyperkalemia:
report of three cases. Am J Kidney Dis. 1994;24(4):578–80.
33. Quan DJ, Kayser SR. Ketorolac induced acute renal failure following a single dose. J Toxicol Clin Toxicol
1994;32(3):305–09.
34. Freedland SJ, Blanco-Yarosh M et al. Effect of ketorolac on renal function after donor nephrectomy.
Urology 2002;59(6):826–30.
35. Feldman HI, Kinman JL, Berlin JA, et al. Parenteral ketorolac: the risk for acute renal failure. Ann
Intern Med 1997;126(3):193–99.
36. Lee A, Cooper MG, Craig JC, et al. The effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on postoperative renal function: a meta-analysis. Anaesth Intensive Care 1999;27(6):574–80.
37. Sharma S, Chang DW, Koutz C, et al. Incidence of hematoma associated with ketorolac after TRAM
flap breast reconstruction. Plast Reconstr Surg 2001;107(2):352–55.
38. Milne JC, Russell JA, Woods GW, Dalton MD. Effect of ketorolac tromethamine (Toradol) on ecchymosis following anterior cruciate ligament reconstruction. Am J Knee Surg 1995;8(1):24–7.
39. Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory
drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998; 158(1):33–9.
40. Reinhart DI. Minimising the adverse effects of ketorolac. Drug Saf 2000;22(6):487–97.


Об авторах / Для корреспонденции


Котова Ольга Владимировна – невролог, старший научный сотрудник отдела патологии вегетативной нервной системы НИЦ ГОУ ВПО “Первый Московский государственный университет им. И.М. Сеченова”. E-mail: ol_kotova@mail.ru


Похожие статьи


Бионика Медиа